Who We Are

The Company

Luciole is a start-up company focusing on the discovery and development of small molecules that accelerate the repair of oxidative damage to mitochondrial DNA (mtDNA).  The company combines decades of expertise in mitochondrial function, drug discovery and development, and use of the virtual company model to become the leader in correcting oxidative damage to mtDNA.

Luciole is applying cutting edge science to enhance the functionality of OGG1 (8-oxoguanine DNA glycosylase, the key enzyme in the initiation of base excision repair (BER) of mtDNA

The Management Team
Dennis Goldberg, PhD
President and CEO, Co-founder
Bill Rumsey, PhD
Vice President and CSO, Co-founder
Eric Morrel, PhD
Vice President and COO, Co-founder
Scientific Advisors

Stephen Lloyd, PhD, Co-founder

Professor, Molecular and Medical Genetics, School of Medicine, Oregon Health and Science University

Stephen K. Bencovic, PhD

Evan Pugh University Professor and Eberly Chair in Chemistry

Pennsylvania State University

 

Brett Kaufman, PhD

Associate Professor of Medicine

University of Pittsburgh

5 Commonwealth Rd, Suite 2A,  Natick, MA 01760

Phone:  508-651-3700

e-mail:   info@luciolepharma.com

Copyright©2020LuciolePharmaceuticals